[HTML][HTML] Brain malignancies: Glioblastoma and brain metastases

TT Lah, M Novak, B Breznik - Seminars in cancer biology, 2020 - Elsevier
Brain, the major organ of the central nervous system controls and processes most of body
activities. Therefore, the most aggressive brain tumor–glioblastoma and metastases from …

Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme

MK Kranjc, M Novak, RG Pestell, TT Lah - Radiology and oncology, 2019 - sciendo.com
Background. Glioblastoma is the most frequent and aggressive brain tumour in humans with
median survival from 12 to 15 months after the diagnosis. This is mostly due to therapy …

Glioblastoma stem cell-derived exosomes enhance stemness and tumorigenicity of glioma cells by transferring Notch1 protein

Z Sun, LI Wang, Y Zhou, L Dong, W Ma, L Lv… - Cellular and molecular …, 2020 - Springer
Exosomes contain plenty of bioactive information, playing an important role in intercellular
communication by transfer their bioactive molecular contents to recipient cells. Glioblastoma …

P53 status, and G2/M cell cycle arrest, are determining factors in cell-death induction mediated by ELF-EMF in glioblastoma

R Mehdizadeh, A Madjid Ansari, F Forouzesh… - Scientific reports, 2023 - nature.com
The average survival of patients with glioblastoma is 12–15 months. Therefore, finding a
new treatment method is important, especially in cases that show resistance to treatment …

CCR5-Mediated Signaling is Involved in Invasion of Glioblastoma Cells in Its Microenvironment

M Novak, M Koprivnikar Krajnc, B Hrastar… - International journal of …, 2020 - mdpi.com
The chemokine CCL5/RANTES is a versatile inflammatory mediator, which interacts with the
receptor CCR5, promoting cancer cell interactions within the tumor microenvironment …

[HTML][HTML] Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines

B Breznik, H Motaln, M Vittori, A Rotter, TL Turnšek - Oncotarget, 2017 - ncbi.nlm.nih.gov
Glioblastoma multiforme are an aggressive form of brain tumors that are characterized by
distinct invasion of single glioblastoma cells, which infiltrate the brain parenchyma. This …

[HTML][HTML] Photodynamic therapy of Glioblastoma cells using doped conjugated polymer nanoparticles: An in vitro comparative study based on redox status

MD Caverzán, L Beaugé, CA Chesta… - … of Photochemistry and …, 2020 - Elsevier
Due to their superb light absorption and photostability conjugated polymer nanoparticles are
promising photosensitizers (PS) for their use in Photodynamic therapy (PDT). Recently, we …

[HTML][HTML] Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma

PE Saw, X Xu, BR Kang, J Lee, YS Lee, C Kim… - Theranostics, 2021 - ncbi.nlm.nih.gov
Extra-domain B of fibronectin (EDB-FN) is an alternatively spliced form of fibronectin with
high expression in the extracellular matrix of neovascularized tissues and malignant cancer …

Using a Dual CRISPR/Cas9 Approach to Gain Insight into the Role of LRP1B in Glioblastoma

J Peixoto, C Príncipe, A Pestana, H Osório… - International Journal of …, 2023 - mdpi.com
LRP1B remains one of the most altered genes in cancer, although its relevance in cancer
biology is still unclear. Recent advances in gene editing techniques, particularly …

Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events

LE Ibarra, ML Vilchez, MD Caverzán… - Journal of …, 2021 - Wiley Online Library
Photodynamic therapy (PDT) has recently gained attention as an alternative treatment of
malignant gliomas. Glioblastoma (GBM) is the most prevalent within tumors of the central …